TAVI versus SAVR in aortic stenosis, is the debate still relevant in 2026?

In this discussion, Helge Möllman and Eberhard Grube revisit the ongoing debate between TAVI and surgery in the treatment of aortic stenosis. While TAVI continues to expand into younger and more complex patient populations, they emphasise that the dialogue with cardiac surgery remains essential. They highlight the importance of collaboration rather than competition, especially as decisions increasingly rely on long-term valve durability, anatomical considerations such as bicuspid valves, and lifetime patient management. Ultimately, both agree that combining expertise across disciplines is key to selecting the best strategy for each patient and achieving optimal outcomes.